Company intelligence / Profile preview

Jenner Biotherapies

Walworth, Wisconsin, United States

Ownership: Private
Development stage: Other

Overview

Programs developed by Jenner Biotherapies (including JBT-3002 and Oncovax-CL) were discontinued before or near clinical stage; limited available clinical data, with some program(s) never progressing beyond preclinical or early clinical

Therapeutic areas: Oncology
Modalities: ImmunostimulantVaccine
Industry: Biotech

Beyond the preview

Go deeper on Jenner Biotherapies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jenner Biotherapies.

Explore the full profile